Bulletin
Investor Alert

The Wall Street Journal Archives | Email alerts

May 25, 2022, 11:40 p.m. EDT

CVS and Walmart to stop filling controlled-substance prescriptions for telehealth companies Cerebral, Done

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    CVS Health Corp. (CVS)
  • X
    Walmart Inc. (WMT)

or Cancel Already have a watchlist? Log In

Rolfe Winkler, Sarah Nassauer

CVS Health Corp. and Walmart Inc. will stop filling prescriptions for controlled substances ordered by clinicians working for Cerebral Inc. and Done Health, the broadest curbs yet by major pharmacies against the telehealth companies following  scrutiny of their prescription practices .

A CVS /zigman2/quotes/209664499/composite CVS +1.38% spokesman confirmed the change, citing concerns with the two companies following a review it conducted. Cerebral had earlier disclosed the change to The Wall Street Journal. A Walmart /zigman2/quotes/207374728/composite WMT +0.86% spokeswoman said the retail giant is taking steps to no longer fill those prescriptions but didn’t elaborate on why it made the decision.

“Walmart is committed to patient safety and well-being,” the spokeswoman said. “We have an audit and compliance process in place that guides our decisions.”

Walmart, the largest retailer by revenue, operates some 5,000 U.S. pharmacy locations and last year  bought a telehealth startup  now called Walmart Health Virtual Care. That unit doesn’t prescribe controlled substances, the spokeswoman said.

Cerebral called CVS’s decision unfortunate, adding that it was “doing everything possible to ensure these patients get access to medications that their healthcare providers have determined they need.”

An expanded version of this report appears on WSJ.com.

Also popular on WSJ.com:

How old are you really? Meet your ‘biological age.’

Sleeping in when you work from home does more harm than good. Here’s why.

/zigman2/quotes/209664499/composite
US : U.S.: NYSE
$ 93.94
+1.28 +1.38%
Volume: 5.22M
July 1, 2022 4:00p
P/E Ratio
15.60
Dividend Yield
2.34%
Market Cap
$121.51 billion
Rev. per Employee
$999,037
loading...
/zigman2/quotes/207374728/composite
US : U.S.: NYSE
$ 122.63
+1.05 +0.86%
Volume: 5.82M
July 1, 2022 4:00p
P/E Ratio
26.35
Dividend Yield
1.83%
Market Cap
$333.27 billion
Rev. per Employee
$250,440
loading...

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.